Shares of Sivers Semiconductors (SIVEF) dropped 9.4% to $3.38 on August 27 after the Swedish chip maker's Q2 report revealed a widening gap between its forward-looking narrative and its present-day financials — raising the central question of how long investors will fund a story that keeps getting pushed into the future.

  • Sales Fell While the Company Says It's Growing on Purpose. Net sales dropped 12% year-over-year to SEK 53.8 million, adjusted EBITDA worsened to negative SEK 35.5 million, and earnings per share slid to SEK −0.38. Management frames the decline as deliberate: Sivers is transitioning from one-time development-services revenue (called NRE) toward repeatable product sales, and scaling down those older contracts weighed on near-term financials.

Product revenue did rise 18% year-over-year on a currency-adjusted basis , but it wasn't nearly enough to offset the NRE runoff. For shareholders, the headline is simple: total revenue shrank for the second straight quarter.

  • Cash Is Draining Faster Than Revenue Is Arriving. Operating cash flow hit negative SEK 70.0 million, more than triple the SEK −20.1 million burned a year earlier.

For the full first half of 2026, net sales fell 20% to SEK 115.6 million, and operating losses widened significantly.

To stay solvent, Sivers raised roughly SEK 825 million in fresh equity during the quarter — diluting existing holders. The math is stark: the company is spending far more than it earns, and survival depends on continued capital-market generosity.

  • A Massive Pipeline Remains Unsigned Revenue. The opportunity pipeline ballooned to USD 1.2 billion in July, up 268% from December 2025. That sounds impressive, but a pipeline is a list of potential deals, not booked orders. Sivers expects results to become visible in Q4 2026 and accelerate through 2027 as programs move toward volume production.

Analysts have warned that failure to reach roughly SEK 1.25 billion in revenue with 40% gross margins by 2028 risks severe downside.

  • The Valuation Already Assumes a Turnaround. With a $972 million market cap, Sivers trades at roughly 35× trailing sales — a premium usually reserved for proven hypergrowth companies, not firms with shrinking revenue and deepening losses. As one analyst put it, "the operating story has improved, but current revenue growth and profitability still lag far behind what the share price implies." Until cash flow inflects, the stock remains a bet on 2027 — and 2027 isn't here yet.